Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.51 |
| ▸ | STAT3 | P40763 | 13/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.45 |
| ▸ | PRKAA2 | P54646 | 2/20 | 0.45 |
| ▸ | LSS | P48449 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3065446 | 0.84 | STAT3 (0.54) | PTGS2STAT3DRD2DRD3PIK3CA | |
| SCHEMBL3052004 | 0.83 | STAT3 (0.62) | STAT3 | |
| SCHEMBL3057622 | 0.82 | STAT3 (0.53) | PTGS2STAT3DRD2DRD3PIK3CA | |
| SCHEMBL3065449 | 0.82 | STAT3 (0.53) | PTGS2STAT3DRD2DRD3PIK3CA | |
| Bromide SCHEMBL3067852 | 0.81 | STAT3 (0.53) | PTGS2STAT3DRD2DRD3PIK3CA | |
| Bromide SCHEMBL3063277 | 0.81 | STAT3 (0.53) | PTGS2STAT3DRD2DRD3PIK3CA | |
| Maleic Acid SCHEMBL3064256 | 0.80 | STAT3 (0.51) | PTGS2STAT3DRD2DRD3PIK3CA | |
| SCHEMBL3064421 | 0.79 | STAT3 (0.52) | PTGS2STAT3DRD2DRD3PIK3CA | |
| SCHEMBL3060710 | 0.78 | STAT3 (0.51) | PTGS2STAT3DRD2DRD3PIK3CA | |
| Fumaric Acid SCHEMBL3064261 | 0.76 | STAT3 (0.49) | PTGS2STAT3DRD2DRD3PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2207773-B1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | OTSUKA PHARMA CO LTD (JP) | 2012-07-11 | — | — | EP | disclosed |